
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6222704
[patent_doc_number] => 20100056485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'NANOSOAP CONTAINING SILVER NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/200817
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9318
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056485.pdf
[firstpage_image] =>[orig_patent_app_number] => 12200817
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/200817 | NANOSOAP CONTAINING SILVER NANOPARTICLES | Aug 27, 2008 | Abandoned |
Array
(
[id] => 4759960
[patent_doc_number] => 20080312186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'KETONES AND REDUCED KETONES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/193855
[patent_app_country] => US
[patent_app_date] => 2008-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 35154
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312186.pdf
[firstpage_image] =>[orig_patent_app_number] => 12193855
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/193855 | Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions | Aug 18, 2008 | Issued |
Array
(
[id] => 5310912
[patent_doc_number] => 20090018193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS'
[patent_app_type] => utility
[patent_app_number] => 12/192627
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1542
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018193.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192627
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192627 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS | Aug 14, 2008 | Abandoned |
Array
(
[id] => 151657
[patent_doc_number] => 07683047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-23
[patent_title] => 'Treatment of conditions relating to hormone deficiencies by administration of progestins'
[patent_app_type] => utility
[patent_app_number] => 12/192352
[patent_app_country] => US
[patent_app_date] => 2008-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5722
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/683/07683047.pdf
[firstpage_image] =>[orig_patent_app_number] => 12192352
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/192352 | Treatment of conditions relating to hormone deficiencies by administration of progestins | Aug 14, 2008 | Issued |
Array
(
[id] => 5337840
[patent_doc_number] => 20090054304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/188789
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16657
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054304.pdf
[firstpage_image] =>[orig_patent_app_number] => 12188789
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/188789 | HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE | Aug 7, 2008 | Abandoned |
Array
(
[id] => 102882
[patent_doc_number] => 07723392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Use of RR/SR-ractopamine'
[patent_app_type] => utility
[patent_app_number] => 12/221780
[patent_app_country] => US
[patent_app_date] => 2008-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19108
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723392.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221780
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221780 | Use of RR/SR-ractopamine | Aug 5, 2008 | Issued |
Array
(
[id] => 8549394
[patent_doc_number] => 08324277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Nitrated-fatty acids modulation of type II diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/670951
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2904
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670951 | Nitrated-fatty acids modulation of type II diabetes | Jul 31, 2008 | Issued |
Array
(
[id] => 6424431
[patent_doc_number] => 20100168072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Drug Combinations for the Treatment of Duchenne Muscular Dystrophy'
[patent_app_type] => utility
[patent_app_number] => 12/600240
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23724
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168072.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600240
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600240 | Drug Combinations for the Treatment of Duchenne Muscular Dystrophy | Jul 31, 2008 | Abandoned |
Array
(
[id] => 6237095
[patent_doc_number] => 20100267837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'USE OF AT LEAST ONE OXIME DERIVATIVE OF 3,5-SECO-4-NOR-CHOLESTANE AS ANTIOXIDANTS'
[patent_app_type] => utility
[patent_app_number] => 12/670482
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6741
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670482
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670482 | Use of at least one oxime derivative of 3,5-seco-4-nor-cholestane as antioxidants | Jul 23, 2008 | Issued |
Array
(
[id] => 7530503
[patent_doc_number] => 07842725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Foaming alcohol compositions with selected dimethicone surfactants'
[patent_app_type] => utility
[patent_app_number] => 12/179382
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4780
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842725.pdf
[firstpage_image] =>[orig_patent_app_number] => 12179382
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/179382 | Foaming alcohol compositions with selected dimethicone surfactants | Jul 23, 2008 | Issued |
Array
(
[id] => 8527824
[patent_doc_number] => 08304394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Low side effect pharmaceutical composition containing isoniazid'
[patent_app_type] => utility
[patent_app_number] => 13/059929
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9227
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059929
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059929 | Low side effect pharmaceutical composition containing isoniazid | Jul 22, 2008 | Issued |
Array
(
[id] => 8363675
[patent_doc_number] => 08252742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Methods for enhancing the quality of life of a senior animal'
[patent_app_type] => utility
[patent_app_number] => 12/176331
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17729
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12176331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/176331 | Methods for enhancing the quality of life of a senior animal | Jul 17, 2008 | Issued |
Array
(
[id] => 4540172
[patent_doc_number] => 07875622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-25
[patent_title] => 'Methods and compositions for treating pulmonary hypertension and related diseases and disorders'
[patent_app_type] => utility
[patent_app_number] => 12/169815
[patent_app_country] => US
[patent_app_date] => 2008-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32714
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/875/07875622.pdf
[firstpage_image] =>[orig_patent_app_number] => 12169815
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/169815 | Methods and compositions for treating pulmonary hypertension and related diseases and disorders | Jul 8, 2008 | Issued |
Array
(
[id] => 6482665
[patent_doc_number] => 20100008896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'Use of Fenretinide or Bioactive Derivatives Thereof and Pharmaceutical Compositions Comprising the Same'
[patent_app_type] => utility
[patent_app_number] => 12/169532
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 14822
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20100008896.pdf
[firstpage_image] =>[orig_patent_app_number] => 12169532
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/169532 | Use of fenretinide or bioactive derivatives thereof and pharmaceutical compositions comprising the same | Jul 7, 2008 | Issued |
Array
(
[id] => 4960699
[patent_doc_number] => 20080275124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'POWDER OF AMINO ACIDS AND METHOD FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/168566
[patent_app_country] => US
[patent_app_date] => 2008-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5540
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275124.pdf
[firstpage_image] =>[orig_patent_app_number] => 12168566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/168566 | Powder of amino acids and method for producing the same | Jul 6, 2008 | Issued |
Array
(
[id] => 6629536
[patent_doc_number] => 20100004278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'DEXTROMETHORPHAN HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 12/167778
[patent_app_country] => US
[patent_app_date] => 2008-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3270
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004278.pdf
[firstpage_image] =>[orig_patent_app_number] => 12167778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/167778 | Dextromethorphan hydrochloride | Jul 2, 2008 | Issued |
Array
(
[id] => 5447066
[patent_doc_number] => 20090048292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'SYNERGISTIC COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 12/163125
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15174
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048292.pdf
[firstpage_image] =>[orig_patent_app_number] => 12163125
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/163125 | SYNERGISTIC COMBINATION | Jun 26, 2008 | Abandoned |
Array
(
[id] => 111980
[patent_doc_number] => 07718634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Method of treatment using bisphosphonic acid'
[patent_app_type] => utility
[patent_app_number] => 12/139587
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3148
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718634.pdf
[firstpage_image] =>[orig_patent_app_number] => 12139587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/139587 | Method of treatment using bisphosphonic acid | Jun 15, 2008 | Issued |
Array
(
[id] => 92348
[patent_doc_number] => 07737175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-15
[patent_title] => 'Methods and compositions for regulating HDAC4 activity'
[patent_app_type] => utility
[patent_app_number] => 12/130394
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12868
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/737/07737175.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130394
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130394 | Methods and compositions for regulating HDAC4 activity | May 29, 2008 | Issued |
Array
(
[id] => 4791611
[patent_doc_number] => 20080292584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'METAXALONE PRODUCTS, METHOD OF MANUFACTURE, AND METHOD OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/127930
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34910
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292584.pdf
[firstpage_image] =>[orig_patent_app_number] => 12127930
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/127930 | METAXALONE PRODUCTS, METHOD OF MANUFACTURE, AND METHOD OF USE | May 27, 2008 | Abandoned |